-
Mashup Score: 8Interdisciplinary GU Cancer Forum 2025: Novel Agents in Metastatic Urothelial Carcinoma - 5 day(s) ago
Interdisciplinary GU Cancer Forum 2025, Metastatic Urothelial Carcinoma, enfortumab vedotin, Nectin-4 antibody drug conjugate, CRB-701, BT8009-100, DURAVELO-1 trial, DURAVELO-2 trial, zelenectide pevedotin, pembrolizumab, zelenectide pevedotin and pembrolizumab, B440.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7Interdisciplinary GU Cancer Forum 2025: What is the Optimal Sequence of Treatment for Metastatic Urothelial Carcinoma? - 5 day(s) ago
Interdisciplinary GU Cancer Forum 2025, urothelial carcinoma, Metastatic Urothelial Carcinoma, enfortumab vedotin, advanced urothelial carcinoma when enfortumab vedotin, Optimal Sequence of Treatment for Metastatic Urothelial Carcinoma, pembrolizumab, EV-301 trial, trastuzumab deruxtecan, DESTINY-PanTumor02 trial, THOR trial, erdafitinib, EV-302 trial, carboplatin.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Interdisciplinary #GUCancerForum 2025: What is the optimal sequence of treatment for metastatic #UrothelialCarcinoma? Presentation by @DanielPetrylak @YaleMedicine. Written coverage by @zklaassen_md @GACancerCenter > https://t.co/2gz2p22pXA https://t.co/4kXtp2tjhZ
-
-
Mashup Score: 9Interdisciplinary GU Cancer Forum 2025: New Approaches to Neoadjuvant Therapy for Urothelial Carcinoma - 5 day(s) ago
urothelial carcinoma, muscle invasive bladder cancer (MIBC), NIAGARA trial, perioperative immune checkpoint inhibitor, durvalumab, enfortumab vedotin, KEYNOTE-905/EV-303 trial, VOLGA trial.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Interdisciplinary #GUCancerForum 2025: New approaches to neoadjuvant therapy for #UrothelialCarcinoma. Presented by @DanielPetrylak @YaleCancer. Written coverage by @zklaassen_md @GACancerCenter https://t.co/xayLYslOPM https://t.co/aqGKA04HNm
-
Interdisciplinary #GUCancerForum 2025: Novel agents in metastatic #UrothelialCarcinoma. Presentation by @DanielPetrylak @YaleMedicine. Written coverage by @zklaassen_md @GACancerCenter > https://t.co/j2IgfvdfvK https://t.co/yKfmpTt4Za